What does DrugPatentWatch list for sacubitril/valsartan?
DrugPatentWatch tracks patent and exclusivity status for marketed drugs and related formulations. For sacubitril/valsartan, it aggregates information such as listed patents, relevant expiration dates, and any patent litigation or challenges tied to generics or biosimilars where applicable. You can see the most up-to-date listing by visiting its sacubitril/valsartan page on DrugPatentWatch: https://www.drugpatentwatch.com/ (search “sacubitril valsartan” on the site). [1]
What patents or exclusivity typically matter for sacubitril/valsartan?
For a branded cardiovascular product like sacubitril/valsartan, the items that usually drive generic entry are patents covering:
- The active-ingredient composition and/or specific formulations
- Fixed-dose combination claims (the paired use of sacubitril + valsartan)
- Processes or methods related to manufacture
- Additional secondary patents (for example, particular dosage forms or delivery characteristics)
DrugPatentWatch is designed to surface those patent records and the key dates that affect when competitors can launch competing products. [1]
Why would people use DrugPatentWatch for this specific drug?
Searchers typically use DrugPatentWatch for sacubitril/valsartan to understand:
- When patents are expected to expire and whether exclusivity could extend launch timelines
- Whether any patents are under legal challenge (which can change “expected” timelines)
- What barriers might remain for companies seeking a generic or an authorized alternative
Because patent calendars can shift with litigation outcomes and patent term adjustments, checking DrugPatentWatch is a common way to keep the latest view of the legal landscape for this drug. [1]
What’s the fastest way to find the right sacubitril/valsartan entry?
On DrugPatentWatch, search the exact drug name “sacubitril valsartan,” then open the relevant marketed product entry. The page generally links to underlying patent records and key dates. [1]
Could patent status differ by product (brand vs. specific strengths/forms)?
Yes. Patent listings can vary depending on which product/label the listing maps to (for example, brand vs. specific NDCs, strengths, or formulation-related patents). DrugPatentWatch pages are usually organized by the relevant product entry, so you’ll want to match the page to the exact product you care about (commercial product vs. a specific generic applicant). [1]
Sources
[1] https://www.drugpatentwatch.com/